Air Methods – Regulatory Headwinds & Operational Analysis – 14 December 2021

  • Private Equity
  • Healthcare
  • North America


Former VP at Air Methods Corp


  • Recent US air ambulance industry trends and developments
  • No Surprises Act implications in 2022 on top-line revenues
  • Controlled misses' impact on margins and ability to reduce these operational challenges
  • Air Methods' (NASDAQ: AIRM) ability to cut costs and preserve capital
  • Competitive dynamics and relative positioning vs other key players, including GMR, PHI Air and Air Medical
  • 2022 outlook – further consolidation and industry recovery


Gain access to Premium Content

Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.

    One week, unlimited access to over 25,000 transcripts
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited